NBRV Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: Arbutus Biopharma Corporation - Mentions: ABUS BMY KRYS

Arbutus Appoints Two New Executives

3 years ago - By: InvestorPlace - Mentions: ATNF EBON RIBT IFRX ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

3 years ago - By: InvestorPlace - Mentions: BBBY SPCE RDFN RKT ...

7 Stocks to Sell as Banks Melt Down

3 years ago - By: Seeking Alpha

NBRV stock on watch as Merck ends distribution agreement (NASDAQ:NBRV)

3 years ago - By: Benzinga - Mentions: CERS CUTR PCQ DLHC ...

Stocks That Hit 52-Week Lows On Monday

3 years ago - By: Benzinga - Mentions: TNXP ORTX IFBD ELEV ...

Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session

3 years ago - By: Nabriva Therapeutics US, Inc

Nabriva Therapeutics Provides Corporate Update

3 years ago - By: Seeking Alpha

NBRV stock gains after announcing Phase 1 data for cystic fibrosis candidate (NASDAQ:NBRV)

3 years ago - By: Nabriva Therapeutics US, Inc

Nabriva Therapeutics Announces Positive Topline Results from Phase 1 Trial of XENLETA® (lefamulin) in Adult Patients with Cystic Fibrosis

3 years ago - By: Nabriva Therapeutics US, Inc

Nabriva Therapeutics Pivoting Strategic Focus Reports Third Quarter Financial Results and Provides Corporate Update

3 years ago - By: Nabriva Therapeutics US, Inc

Nabriva Therapeutics to Report Third Quarter 2022 Financial Results and Recent Corporate Highlights on November 10, 2022

3 years ago - By: InvestorPlace - Mentions: RGTI NVDA AAOI UBER

Rigetti (RGTI) Stock Pops on New Quantum Computing Partners

3 years ago - By: InvestorPlace - Mentions: GMBL NTLA GE

Why Is Esports Entertainment (GMBL) Stock Down 45% Today?

3 years ago - By: InvestorPlace - Mentions: UBER GE FDX

What Is Going on With Nabriva Therapeutics (NBRV) Stock Today?

3 years ago - By: InvestorPlace - Mentions: AMPX AAOI SYRS QTNT ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

3 years ago - By: Nabriva Therapeutics US, Inc

Nabriva Therapeutics Announces Date of 1-for-25 Reverse Stock Split

3 years ago - By: InvestorPlace - Mentions: KERN ADTX ZVO DWIN ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

3 years ago - By: Nabriva Therapeutics US, Inc

Nabriva Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

3 years ago - By: Nabriva Therapeutics US, Inc

Nabriva Therapeutics Completes Patient Enrollment in Phase 1 Trial of XENLETA® (lefamulin) in Adult Patients with Cystic Fibrosis

3 years ago - By: Nabriva Therapeutics US, Inc

Nabriva Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update

3 years ago - By: Nabriva Therapeutics US, Inc

Nabriva Therapeutics to Report Second Quarter 2022 Financial Results and Recent Corporate Highlights on August 3, 2022

3 years ago - By: Nabriva Therapeutics US, Inc

Nabriva Therapeutics Expands XENLETA® (lefamulin) Presence with Exclusive Agreement with Er-Kim Pharmaceuticals

3 years ago - By: InvestorPlace - Mentions: XCUR REVB MARK SCWO ...

NABRIVA THERAPEUTICS PLC (NBRV) Stock News

NBRV Latest News, Press Relases and Analysis

Arbutus Appoints Two New Executives

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

7 Stocks to Sell as Banks Melt Down

NBRV stock on watch as Merck ends distribution agreement (NASDAQ:NBRV)

Stocks That Hit 52-Week Lows On Monday

Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Nabriva Therapeutics Provides Corporate Update

NBRV stock gains after announcing Phase 1 data for cystic fibrosis candidate (NASDAQ:NBRV)

Nabriva Therapeutics Announces Positive Topline Results from Phase 1 Trial of XENLETA® (lefamulin) in Adult Patients with Cystic Fibrosis

Nabriva Therapeutics Pivoting Strategic Focus Reports Third Quarter Financial Results and Provides Corporate Update

Nabriva Therapeutics to Report Third Quarter 2022 Financial Results and Recent Corporate Highlights on November 10, 2022

Rigetti (RGTI) Stock Pops on New Quantum Computing Partners

Why Is Esports Entertainment (GMBL) Stock Down 45% Today?

What Is Going on With Nabriva Therapeutics (NBRV) Stock Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Nabriva Therapeutics Announces Date of 1-for-25 Reverse Stock Split

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Nabriva Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

Nabriva Therapeutics Completes Patient Enrollment in Phase 1 Trial of XENLETA® (lefamulin) in Adult Patients with Cystic Fibrosis

Nabriva Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update

Nabriva Therapeutics to Report Second Quarter 2022 Financial Results and Recent Corporate Highlights on August 3, 2022

Nabriva Therapeutics Expands XENLETA® (lefamulin) Presence with Exclusive Agreement with Er-Kim Pharmaceuticals

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday